These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1625191)

  • 1. Attenuation of amiodarone-induced lung fibrosis and phospholipidosis in hamsters by taurine and/or niacin treatment.
    Wang Q; Hollinger MA; Giri SN
    J Pharmacol Exp Ther; 1992 Jul; 262(1):127-32. PubMed ID: 1625191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abatement of bleomycin-induced increases in vascular permeability, inflammatory cell infiltration, and fibrotic lesions in hamster lungs by combined treatment with taurine and niacin.
    Wang Q; Hyde DM; Giri SN
    Lab Invest; 1992 Aug; 67(2):234-42. PubMed ID: 1380105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary responses to amiodarone in hamsters: comparison of intratracheal and oral administrations.
    Blake TL; Reasor MJ
    Toxicol Appl Pharmacol; 1995 Apr; 131(2):325-31. PubMed ID: 7716773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin.
    Wang QJ; Giri SN; Hyde DM; Li C
    Biochem Pharmacol; 1991 Aug; 42(5):1115-22. PubMed ID: 1714734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurine and niacin offer a novel therapeutic modality in prevention of chemically-induced pulmonary fibrosis in hamsters.
    Giri SN; Wang Q
    Adv Exp Med Biol; 1992; 315():329-40. PubMed ID: 1380762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procollagen gene expression is down-regulated by taurine and niacin at the transcriptional level in the bleomycin hamster model of lung fibrosis.
    Gurujeyalakshmi G; Iyer SN; Hollinger MA; Giri SN
    J Pharmacol Exp Ther; 1996 May; 277(2):1152-7. PubMed ID: 8627527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice.
    Gurujeyalakshmi G; Wang Y; Giri SN
    J Pharmacol Exp Ther; 2000 Apr; 293(1):82-90. PubMed ID: 10734156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of bleomycin-induced lung fibrosis in hamsters by dietary supplementation with taurine and niacin: biochemical mechanisms.
    Giri SN; Blaisdell R; Rucker RB; Wang Q; Hyde DM
    Environ Health Perspect; 1994 Dec; 102 Suppl 10(Suppl 10):137-47. PubMed ID: 7535685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of amiodarone-induced pulmonary fibrosis by vitamin E is associated with suppression of transforming growth factor-beta1 gene expression but not prevention of mitochondrial dysfunction.
    Card JW; Racz WJ; Brien JF; Massey TE
    J Pharmacol Exp Ther; 2003 Jan; 304(1):277-83. PubMed ID: 12490602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
    Iyer SN; Wild JS; Schiedt MJ; Hyde DM; Margolin SB; Giri SN
    J Lab Clin Med; 1995 Jun; 125(6):779-85. PubMed ID: 7539478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of repeated administration of N-acetyl-L-cysteine on sulfhydryl levels of different tissues and bleomycin-induced lung fibrosis in hamsters.
    Giri SN; Hyde DM; Schiedt MJ
    J Lab Clin Med; 1988 Jun; 111(6):715-24. PubMed ID: 2453601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A characterization of amiodarone-induced pulmonary toxicity in F344 rats and identification of surfactant protein-D as a potential biomarker for the development of the toxicity.
    Taylor MD; Van Dyke K; Bowman LL; Miles PR; Hubbs AF; Mason RJ; Shannon K; Reasor MJ
    Toxicol Appl Pharmacol; 2000 Sep; 167(3):182-90. PubMed ID: 10986009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the in vivo pulmonary toxicity of amiodarone and des-oxo-amiodarone in the hamster.
    Rafeiro E; Leeder RG; Brien JF; Kabalka GW; Chatla N; Massey TE
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):275-81. PubMed ID: 8048071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical mechanisms for the attenuation of bleomycin-induced lung fibrosis by treatment with niacin in hamsters: the role of NAD and ATP.
    O'Neill CA; Giri SN
    Exp Lung Res; 1994; 20(1):41-56. PubMed ID: 7514122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of antifibrotic effect of taurine and niacin in the multidose bleomycin-hamster model of lung fibrosis: inhibition of lysyl oxidase and collagenase.
    Blaisdell RJ; Giri SN
    J Biochem Toxicol; 1995 Aug; 10(4):203-10. PubMed ID: 8568834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of niacin on bleomycin-induced increases in myeloperoxidase, prolyl hydroxylase, and superoxide dismutase activities and collagen accumulation in the lungs of hamsters.
    O'Neill CA; Giri SN
    J Biochem Toxicol; 1992; 7(4):229-39. PubMed ID: 1284083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of bleomycin-induced pulmonary fibrosis by lipopolysaccharide.
    Phan SH; Fantone JC
    Lab Invest; 1984 May; 50(5):587-91. PubMed ID: 6201676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary supplementation with taurine and niacin prevents the increase in lung collagen cross-links in the multidose bleomycin hamster model of pulmonary fibrosis.
    Blaisdell RJ; Schiedt MJ; Giri SN
    J Biochem Toxicol; 1994 Apr; 9(2):79-86. PubMed ID: 7520944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters.
    Wang Q; Hyde DM; Gotwals PJ; Giri SN
    Exp Lung Res; 2002 Sep; 28(6):405-17. PubMed ID: 12217209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of bleomycin-induced fibrosis and inflammation by taurine.
    Schuller-Levis G; Gordon RE; Wang C; Park SY; Park E
    Int Immunopharmacol; 2009 Jul; 9(7-8):971-7. PubMed ID: 19362168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.